- Home
- DCTH vs BYM Comparison
DCTH vs BYM Comparison
Compare DCTH & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- BYM
- Stock Information
- Founded
- DCTH 1988
- BYM 2002
- Country
- DCTH United States
- BYM United States
- Employees
- DCTH N/A
- BYM N/A
- Industry
- DCTH Medical/Dental Instruments
- BYM Investment Managers
- Sector
- DCTH Health Care
- BYM Finance
- Exchange
- DCTH Nasdaq
- BYM Nasdaq
- Market Cap
- DCTH 630.4M
- BYM 270.7M
- IPO Year
- DCTH N/A
- BYM N/A
- Fundamental
- Price
- DCTH $13.57
- BYM $10.48
- Analyst Decision
- DCTH Strong Buy
- BYM
- Analyst Count
- DCTH 4
- BYM 0
- Target Price
- DCTH $24.00
- BYM N/A
- AVG Volume (30 Days)
- DCTH 734.6K
- BYM 60.2K
- Earning Date
- DCTH 08-04-2025
- BYM 01-01-0001
- Dividend Yield
- DCTH N/A
- BYM 4.49%
- EPS Growth
- DCTH N/A
- BYM N/A
- EPS
- DCTH N/A
- BYM N/A
- Revenue
- DCTH $53,850,000.00
- BYM N/A
- Revenue This Year
- DCTH $155.42
- BYM N/A
- Revenue Next Year
- DCTH $37.93
- BYM N/A
- P/E Ratio
- DCTH N/A
- BYM N/A
- Revenue Growth
- DCTH 1068.87
- BYM N/A
- 52 Week Low
- DCTH $7.17
- BYM $9.30
- 52 Week High
- DCTH $18.23
- BYM $11.77
- Technical
- Relative Strength Index (RSI)
- DCTH 38.26
- BYM 47.07
- Support Level
- DCTH $12.98
- BYM $10.40
- Resistance Level
- DCTH $14.18
- BYM $10.49
- Average True Range (ATR)
- DCTH 0.68
- BYM 0.09
- MACD
- DCTH -0.28
- BYM 0.00
- Stochastic Oscillator
- DCTH 15.95
- BYM 31.82
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest
Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.